MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-31-2026
ENDRA Life Sciences EBITDA per Share 2011-2026 | NDRA
Annual EBITDA per Share ENDRA Life Sciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.27 | -53.3 | -1.75 K | -4.12 | -5.35 | -0.59 | -1.43 | -1.92 | -1.66 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.59 | -1.75 K | -203 |
Quarterly EBITDA per Share ENDRA Life Sciences
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.79 | - | -2.59 | - | -6.07 | - | -0.25 | - | -0.37 | -0.4 | -0.92 | - | -0.05 | -0.06 | -0.07 | - | -0.06 | -0.08 | -0.07 | - | -0.13 | -0.19 | -0.27 | - | -0.35 | -0.31 | -0.37 | - | -0.59 | -0.46 | -0.72 | - | -0.22 | -0.42 | -0.48 | - | -0.77 | -0.64 | -0.49 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -0.05 | -6.07 | -0.685 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M |  Canada |
|
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
5.49 | $ 114.8 | -0.71 % | $ 34.9 B |  USA |
 |
Accelerate Diagnostics
AXDX
|
-0.15 | - | -61.36 % | $ 2.46 M | USA |
 |
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
-36.9 | $ 1.62 | -1.82 % | $ 2.15 M | USA |
 |
Illumina
ILMN
|
-3.01 | $ 126.92 | -1.25 % | $ 20.2 B | USA |
 |
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
0.89 | $ 25.04 | 0.24 % | $ 696 M | USA |
 |
Lantheus Holdings
LNTH
|
5.64 | $ 83.68 | -0.51 % | $ 5.65 B | USA |
 |
Check-Cap Ltd.
CHEK
|
-4.41 | - | - | $ 9.42 M |  Israel |
 |
National Research Corporation
NRC
|
1.35 | $ 17.39 | 1.64 % | $ 389 M | USA |
 |
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | USA |
 |
Koninklijke Philips N.V.
PHG
|
0.61 | $ 27.05 | -1.78 % | $ 20 B |  Niderland |
 |
CareDx, Inc
CDNA
|
-0.3 | $ 21.73 | -0.55 % | $ 1.16 B | USA |
 |
Precipio
PRPO
|
0.03 | $ 29.83 | -3.77 % | $ 47.9 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M |  Britain |
 |
Personalis
PSNL
|
-0.97 | $ 5.72 | -4.03 % | $ 339 M | USA |
 |
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | USA |
 |
Senseonics Holdings
SENS
|
-1.6 | $ 7.45 | 2.48 % | $ 311 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-0.43 | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
-1.62 | $ 15.24 | -2.34 % | $ 461 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | China |
 |
Thermo Fisher Scientific
TMO
|
23.3 | $ 466.93 | -0.24 % | $ 176 B | USA |
 |
Trinity Biotech plc
TRIB
|
0.08 | $ 0.63 | -1.88 % | $ 61.9 M |  Irlanda |
 |
Charles River Laboratories International
CRL
|
8.64 | $ 167.34 | -2.27 % | $ 8.29 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-1.86 | $ 59.48 | -2.49 % | $ 3.56 B | USA |
 |
Guardant Health
GH
|
-3.17 | $ 84.53 | -4.49 % | $ 10.6 B | USA |
 |
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
1.02 | $ 1.93 | -2.08 % | $ 8.54 M | USA |
 |
Medpace Holdings
MEDP
|
19.5 | $ 421.64 | 0.06 % | $ 12.2 B | USA |
 |
QIAGEN N.V.
QGEN
|
3.04 | - | - | $ 10.6 B | Niderland |
 |
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K | Israel |
 |
Biomerica
BMRA
|
-2.2 | $ 2.18 | - | $ 5.01 M | USA |
 |
ICON Public Limited Company
ICLR
|
19.2 | $ 101.23 | -1.92 % | $ 8.35 B | Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 261.2 | -0.85 % | $ 21.7 B | USA |
 |
Neogen Corporation
NEOG
|
-4.34 | $ 9.39 | -0.63 % | $ 2.04 B | USA |
 |
Celcuity
CELC
|
-3.68 | $ 123.34 | -1.87 % | $ 5.77 B | USA |
 |
NeoGenomics
NEO
|
-0.62 | $ 8.72 | 1.28 % | $ 1.12 B | USA |
 |
Myriad Genetics
MYGN
|
-3.6 | $ 4.86 | 0.52 % | $ 450 M | USA |
 |
Natera
NTRA
|
-5.33 | $ 200.2 | -2.05 % | $ 19.7 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
19.1 | $ 195.63 | -0.51 % | $ 21.7 B | USA |
 |
Invitae Corporation
NVTA
|
0.2 | - | - | $ 21.2 M | USA |
 |
OpGen
OPGN
|
0.11 | - | -16.95 % | $ 1.54 M | USA |